Physician profile
Hani Sami
NPI 1306891957
$2,846.96
in general payments reported to CMS, 2019-2025
21 companies · $656 in 2025
The $656 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $127 · 2021: $344 · 2022: $276 · 2023: $190 · 2024: $505 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $458.21 | 2019-2025 | Evenity, Krystexxa |
| Janssen Pharmaceuticals, INC | $451.49 | 2021-2022 | |
| Novo Nordisk INC | $344.30 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $277.94 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $198.16 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $178.09 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $157.60 | 2019 | |
| Glaxosmithkline, LLC. | $152.96 | 2019-2024 | Arexvy, Shingrix |
| Abbvie INC. | $121.42 | 2021-2024 | Qulipta, Ubrelvy |
| Exact Sciences Corporation | $93.63 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $92.75 | 2019-2020 | |
| Astellas Pharma US INC | $85.22 | 2019-2025 | Veozah |
| Stryker Corporation | $43.34 | 2024 | Insignia |
| Sanofi Pasteur INC. | $42.28 | 2020-2025 | |
| Allergan, INC. | $42.04 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $28.49 | 2025 | Urolift |
| Phadia US INC. | $18.86 | 2021 | |
| Hologic Sales and Service, LLC | $15.78 | 2019 | |
| Neurocrine Biosciences, INC. | $15.54 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.70 | 2020 | |
| Merck Sharp & Dohme LLC | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Sami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.